Skip to content

Explore Grants

Recipient Purpose Term Source Amount
3 Axis Advisors LLC To help policymakers better understand the economics behind the Medicaid Prescription Drug Program. 2020 - 2022 LJAF $293,250
Abortion Care Network To pilot and evaluate a contraception gap fund and professional development program to support women's healthcare providers. 2018 - 2020 LJAF $602,027
Albert Einstein College of Medicine To conduct a randomized control trial to examine the impact of medical cannabis on opioid analgesic use. 2018 - 2023 LJAF $2,054,259
Alliance for Health Policy To host a bipartisan convening to discuss consolidation trends in health care markets. 2018 LJAF $27,456
Alliance for Health Policy To convene health policy experts, key stakeholders, and policymakers to discuss policy solutions to address rising health care costs. 2018 - 2020 LJAF $201,041
Alliance for Health Policy To educate health policy stakeholders and the public about the ways that prescription drug pricing impacts health care costs. 2016 - 2017 LJAF $156,494
Alliance for Health Policy To further discusions of health care policy solutions. 2020 - 2021 LJAF $238,764
American Society for Cell Biology To support a working group of scientists and policymakers aimed at improving the National Institutes of Health. 2016 - 2017 LJAF $77,183
American Society of Transplant Surgeons To fund a randomized controlled trial evaluating whether reimbursement of lost wages to living kidney donors results in an increased number of living kidney donor applications. 2016 - 2019 LJAF $958,500
Amida Technology Solutions, LLC To facilitate the development of a free, open-source platform that will link disease registries for patients with cancer and Alzheimer?s disease. 2016 - 2017 LJAF $300,000
Association for Community Affiliated Plans To analyze the ways that dual eligible special needs plans are utilizing non-medical supplemental benefits. 2019 - 2020 LJAF $242,281
Behavioral Ideas Lab, Inc. To design, implement, and test a set of behavioral interventions in emergency departments to improve outcomes for patients with opioid use disorder. 2018 - 2019 LJAF $489,230
Bioethics International, Inc. To help expand the Good Pharma Scorecard. 2015 - 2021 LJAF $4,555,858
Bipartisan Policy Center Inc. To analyze policy options related to reference pricing and patent and market exclusivity. 2019 - 2020 LJAF $197,208
Bipartisan Policy Center Inc. To conduct a comprehensive review of how federal and state funding is being allocated to address the opioid epidemic. 2018 - 2019 LJAF $255,042
Bipartisan Policy Center Inc. To conduct a comprehensive review of where federal funding was allocated during the 2019 fiscal year to address the opioid epidemic. 2020 - 2021 LJAF $275,087
Bipartisan Policy Center Inc. To produce informational materials that will guide the evaluation of programs designed to prevent disease and promote a healthy lifestyle. 2014 - 2015 LJAF $288,470
Bipartisan Policy Center Inc. To produce near-term policy recommendations for increasing integration between Medicare and Medicaid. 2019 - 2021 LJAF $308,960
Bipartisan Policy Center Inc. To develop practical solutions for improving quality and controlling costs in the nation's health care system. 2014 - 2015 LJAF $1,244,200
BMJ Publishing Group Limited To produce a report that analyzes the scientific research used to inform the Dietary Guidelines Advisory Committee recommendations. 2015 LJAF $4,000
Board of Regents Nevada System of Higher Education To evaluate the feasibility and effectiveness of the Mobile Recovery Outreach Team intervention in improving outcomes for opioid overdose survivors treated in emergency rooms in Nevada. 2018 - 2019 LJAF $217,445
Board of Regents Nevada System of Higher Education To evaluate the feasibility and effectiveness of the Mobile Recovery Outreach Team intervention on opioid overdose survivors treated in Nevada's emergency rooms. 2019 - 2022 LJAF $1,442,934
Brandeis University To host the 27th Princeton Conference to ignite health policy recommendations for meaningful change. 2019 LJAF $20,000
Brigham & Women's Hospital Inc. To evaluate the impact of Pharmacy Benefits Managers on prescription drug pricing. 2017 - 2018 LJAF $77,315